HK Stock MarketDetailed Quotes

02120 KN HOSPITAL

Watchlist
  • 10.860
  • +0.120+1.12%
Not Open Apr 25 16:09 CST
810.16MMarket Cap8.54P/E (TTM)

KN HOSPITAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
7.50%1.6B
5.37%777.93M
14.45%1.48B
21.48%738.3M
31.18%1.3B
30.65%607.74M
14.91%989.01M
22.76%465.15M
15.38%860.69M
6.20%378.91M
Operating income
7.50%1.6B
5.37%777.93M
14.45%1.48B
21.48%738.3M
31.18%1.3B
30.65%607.74M
14.91%989.01M
22.76%465.15M
15.38%860.69M
6.20%378.91M
Operating expenses
-4.70%-1.19B
-6.63%-576.39M
-16.89%-1.13B
-19.02%-540.54M
-32.81%-968.43M
-34.81%-454.14M
-11.12%-729.17M
-17.42%-336.86M
-32.90%-656.18M
-26.17%-286.88M
Gross profit
16.49%411.14M
1.90%201.53M
7.27%352.93M
28.76%197.77M
26.62%329M
19.73%153.6M
27.06%259.84M
39.40%128.29M
-18.92%204.51M
-28.88%92.03M
Selling expenses
-13.99%-17.1M
-28.00%-7.83M
-45.17%-15M
-24.85%-6.12M
-28.03%-10.34M
-32.50%-4.9M
-1.19%-8.07M
17.42%-3.7M
-55.15%-7.98M
-74.18%-4.48M
Administrative expenses
-3.47%-213.03M
-7.41%-101.92M
-16.73%-205.89M
-24.76%-94.89M
-37.39%-176.37M
-39.21%-76.06M
-4.08%-128.38M
-3.31%-54.64M
-25.85%-123.34M
-3.81%-52.89M
Research and development expenses
1.70%-32.47M
0.69%-14.96M
-18.12%-33.03M
-27.58%-15.06M
-33.33%-27.96M
-347.63%-11.81M
-248.49%-20.97M
-14.47%-2.64M
-4.97%-6.02M
---2.3M
Profit from asset sales
-83.24%68.09K
----
611.55%406.19K
--389.32K
-113.31%-79.4K
----
--596.7K
----
----
-191.42%-18.59K
Revaluation surplus
101.34%214.41K
----
-269.66%-15.98M
-97.73%30.71K
42.70%9.42M
--1.35M
244.16%6.6M
----
--1.92M
----
-Changes in the fair value of other assets
101.34%214.41K
----
-269.66%-15.98M
-97.73%30.71K
42.70%9.42M
--1.35M
244.16%6.6M
----
--1.92M
----
Impairment and provision
73.68%-9.35M
-10.19%-3.01M
-327.15%-35.54M
-18.09%-2.73M
2.07%-8.32M
85.64%-2.31M
70.96%-8.5M
-50.15%-16.11M
-24.39%-29.26M
-55.44%-10.73M
-Other impairment is provision
73.68%-9.35M
-10.19%-3.01M
-327.15%-35.54M
-18.09%-2.73M
2.07%-8.32M
85.64%-2.31M
70.96%-8.5M
-50.15%-16.11M
-24.39%-29.26M
-55.44%-10.73M
Special items of operating profit
-44.20%9.91M
0.02%5.63M
-13.62%17.76M
-47.55%5.63M
795.26%20.56M
137.32%10.73M
-93.39%2.3M
-84.99%4.52M
14,631.70%34.73M
46,220.27%30.12M
Operating profit
135.42%142.9M
-7.64%76.66M
-53.36%60.7M
21.43%83M
32.81%130.15M
27.24%68.35M
41.34%98M
5.56%53.72M
-38.61%69.34M
-22.34%50.89M
Financing cost
6.45%-41.45M
6.88%-20.16M
-17.66%-44.31M
-25.59%-21.65M
-63.18%-37.66M
-45.51%-17.24M
1.75%-23.08M
-16.15%-11.85M
-227.53%-23.49M
-84.42%-10.2M
Special items of earning before tax
-188.42%-2.27M
87.44%3.71M
-124.60%-787.06K
-24.72%1.98M
628.67%3.2M
206.43%2.63M
-106.25%-605.17K
-120.64%-2.47M
748.65%9.68M
1,438.74%11.97M
Earning before tax
535.58%99.18M
-4.93%60.21M
-83.69%15.6M
17.84%63.33M
28.76%95.69M
36.39%53.74M
33.85%74.32M
-25.17%39.4M
-48.07%55.52M
-10.91%52.66M
Tax
53.90%-12.25M
39.94%-11.48M
51.54%-26.57M
-9.16%-19.11M
-78.82%-54.83M
-66.68%-17.51M
-77.29%-30.66M
-47.51%-10.5M
45.85%-17.3M
61.00%-7.12M
After-tax profit from continuing operations
892.53%86.93M
10.20%48.73M
-126.84%-10.97M
22.03%44.22M
-6.40%40.86M
25.39%36.24M
14.20%43.66M
-36.54%28.9M
-49.01%38.23M
11.48%45.54M
Earning after tax
892.53%86.93M
10.20%48.73M
-126.84%-10.97M
22.03%44.22M
-6.40%40.86M
25.39%36.24M
14.20%43.66M
-36.54%28.9M
-49.01%38.23M
11.48%45.54M
Minority profit
-92.58%983.8K
-8.35%4.98M
517.28%13.25M
339.93%5.43M
73.78%-3.18M
116.45%1.23M
36.45%-12.11M
-15.11%-7.51M
-238.79%-19.06M
-474.55%-6.52M
Adjustment items of profit attributable to shareholders
----
----
---1
----
----
----
----
----
----
----
Profit attributable to shareholders
454.85%85.95M
12.79%43.75M
-155.00%-24.22M
10.81%38.79M
-21.04%44.04M
-3.86%35M
-2.65%55.77M
-30.07%36.41M
-28.92%57.29M
24.00%52.06M
Basic earnings per share
459.38%1.15
13.46%0.59
-152.46%-0.32
8.33%0.52
-20.78%0.61
-4.00%0.48
-1.28%0.77
-29.58%0.5
-29.09%0.78
24.56%0.71
Diluted earnings per share
459.38%1.15
13.46%0.59
-154.24%-0.32
8.33%0.52
-21.33%0.59
-4.00%0.48
-2.60%0.75
-28.57%0.5
-29.36%0.77
22.81%0.7
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Qualified opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Lixin Certified Public Accountants (special general partnership)
--
Lixin Certified Public Accountants (special general partnership)
--
Lixin Certified Public Accountants (special general partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 7.50%1.6B5.37%777.93M14.45%1.48B21.48%738.3M31.18%1.3B30.65%607.74M14.91%989.01M22.76%465.15M15.38%860.69M6.20%378.91M
Operating income 7.50%1.6B5.37%777.93M14.45%1.48B21.48%738.3M31.18%1.3B30.65%607.74M14.91%989.01M22.76%465.15M15.38%860.69M6.20%378.91M
Operating expenses -4.70%-1.19B-6.63%-576.39M-16.89%-1.13B-19.02%-540.54M-32.81%-968.43M-34.81%-454.14M-11.12%-729.17M-17.42%-336.86M-32.90%-656.18M-26.17%-286.88M
Gross profit 16.49%411.14M1.90%201.53M7.27%352.93M28.76%197.77M26.62%329M19.73%153.6M27.06%259.84M39.40%128.29M-18.92%204.51M-28.88%92.03M
Selling expenses -13.99%-17.1M-28.00%-7.83M-45.17%-15M-24.85%-6.12M-28.03%-10.34M-32.50%-4.9M-1.19%-8.07M17.42%-3.7M-55.15%-7.98M-74.18%-4.48M
Administrative expenses -3.47%-213.03M-7.41%-101.92M-16.73%-205.89M-24.76%-94.89M-37.39%-176.37M-39.21%-76.06M-4.08%-128.38M-3.31%-54.64M-25.85%-123.34M-3.81%-52.89M
Research and development expenses 1.70%-32.47M0.69%-14.96M-18.12%-33.03M-27.58%-15.06M-33.33%-27.96M-347.63%-11.81M-248.49%-20.97M-14.47%-2.64M-4.97%-6.02M---2.3M
Profit from asset sales -83.24%68.09K----611.55%406.19K--389.32K-113.31%-79.4K------596.7K---------191.42%-18.59K
Revaluation surplus 101.34%214.41K-----269.66%-15.98M-97.73%30.71K42.70%9.42M--1.35M244.16%6.6M------1.92M----
-Changes in the fair value of other assets 101.34%214.41K-----269.66%-15.98M-97.73%30.71K42.70%9.42M--1.35M244.16%6.6M------1.92M----
Impairment and provision 73.68%-9.35M-10.19%-3.01M-327.15%-35.54M-18.09%-2.73M2.07%-8.32M85.64%-2.31M70.96%-8.5M-50.15%-16.11M-24.39%-29.26M-55.44%-10.73M
-Other impairment is provision 73.68%-9.35M-10.19%-3.01M-327.15%-35.54M-18.09%-2.73M2.07%-8.32M85.64%-2.31M70.96%-8.5M-50.15%-16.11M-24.39%-29.26M-55.44%-10.73M
Special items of operating profit -44.20%9.91M0.02%5.63M-13.62%17.76M-47.55%5.63M795.26%20.56M137.32%10.73M-93.39%2.3M-84.99%4.52M14,631.70%34.73M46,220.27%30.12M
Operating profit 135.42%142.9M-7.64%76.66M-53.36%60.7M21.43%83M32.81%130.15M27.24%68.35M41.34%98M5.56%53.72M-38.61%69.34M-22.34%50.89M
Financing cost 6.45%-41.45M6.88%-20.16M-17.66%-44.31M-25.59%-21.65M-63.18%-37.66M-45.51%-17.24M1.75%-23.08M-16.15%-11.85M-227.53%-23.49M-84.42%-10.2M
Special items of earning before tax -188.42%-2.27M87.44%3.71M-124.60%-787.06K-24.72%1.98M628.67%3.2M206.43%2.63M-106.25%-605.17K-120.64%-2.47M748.65%9.68M1,438.74%11.97M
Earning before tax 535.58%99.18M-4.93%60.21M-83.69%15.6M17.84%63.33M28.76%95.69M36.39%53.74M33.85%74.32M-25.17%39.4M-48.07%55.52M-10.91%52.66M
Tax 53.90%-12.25M39.94%-11.48M51.54%-26.57M-9.16%-19.11M-78.82%-54.83M-66.68%-17.51M-77.29%-30.66M-47.51%-10.5M45.85%-17.3M61.00%-7.12M
After-tax profit from continuing operations 892.53%86.93M10.20%48.73M-126.84%-10.97M22.03%44.22M-6.40%40.86M25.39%36.24M14.20%43.66M-36.54%28.9M-49.01%38.23M11.48%45.54M
Earning after tax 892.53%86.93M10.20%48.73M-126.84%-10.97M22.03%44.22M-6.40%40.86M25.39%36.24M14.20%43.66M-36.54%28.9M-49.01%38.23M11.48%45.54M
Minority profit -92.58%983.8K-8.35%4.98M517.28%13.25M339.93%5.43M73.78%-3.18M116.45%1.23M36.45%-12.11M-15.11%-7.51M-238.79%-19.06M-474.55%-6.52M
Adjustment items of profit attributable to shareholders -----------1----------------------------
Profit attributable to shareholders 454.85%85.95M12.79%43.75M-155.00%-24.22M10.81%38.79M-21.04%44.04M-3.86%35M-2.65%55.77M-30.07%36.41M-28.92%57.29M24.00%52.06M
Basic earnings per share 459.38%1.1513.46%0.59-152.46%-0.328.33%0.52-20.78%0.61-4.00%0.48-1.28%0.77-29.58%0.5-29.09%0.7824.56%0.71
Diluted earnings per share 459.38%1.1513.46%0.59-154.24%-0.328.33%0.52-21.33%0.59-4.00%0.48-2.60%0.75-28.57%0.5-29.36%0.7722.81%0.7
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified Opinion--Unqualified Opinion--Qualified opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Lixin Certified Public Accountants (special general partnership)--Lixin Certified Public Accountants (special general partnership)--Lixin Certified Public Accountants (special general partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg